loadpatents
name:-0.037544965744019
name:-0.031089067459106
name:-0.0024290084838867
Hipskind; Philip Arthur Patent Filings

Hipskind; Philip Arthur

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hipskind; Philip Arthur.The latest application filed is for "met antibody drug conjugates".

Company Profile
2.34.32
  • Hipskind; Philip Arthur - New Palestine IN
  • Hipskind; Philip Arthur - New Palastine IN
  • Hipskind; Philip Arthur - Palestine IN
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
MET antibody drug conjugates
Grant 11,167,039 - Feng , et al. November 9, 2
2021-11-09
Met Antibody Drug Conjugates
App 20200061204 - FENG; Yiqing ;   et al.
2020-02-27
Notch pathway signaling inhibitor compounds
Grant 10,450,317 - Clay , et al. Oc
2019-10-22
Notch Pathway Signaling Inhibitor Compounds
App 20180148456 - Clay; Julia Marie ;   et al.
2018-05-31
Disubstituted phthalazine hedgehog pathway antagonists
Grant 9,000,023 - Hipskind , et al. April 7, 2
2015-04-07
Glucagon receptor antagonists, preparation and therapeutic uses
Grant 8,691,856 - Conner , et al. April 8, 2
2014-04-08
Notch pathway signaling inhibitor compound
Grant 8,569,286 - Hipskind , et al. October 29, 2
2013-10-29
Tetrasubstituted pyridazine hedgehog pathway antagonists
Grant 8,507,490 - Bastian , et al. August 13, 2
2013-08-13
Tetrasubstituted pyridazines hedgehog pathway antagonists
Grant 8,445,493 - Bastian , et al. May 21, 2
2013-05-21
Disubstituted phthalazine hedgehog pathway antagonists
Grant 8,404,687 - Bastian , et al. March 26, 2
2013-03-26
Notch Pathway Signaling Inhibitor Compound
App 20130029972 - HIPSKIND; Philip Arthur ;   et al.
2013-01-31
Disubstituted Phthalazine Hedgehog Pathway Antagonists
App 20120316174 - Hipskind; Philip Arthur ;   et al.
2012-12-13
Disubstituted phthalazine hedgehog pathway antagonists
Grant 8,273,742 - Hipskind , et al. September 25, 2
2012-09-25
Histamine H3 receptor agents, preparation and therapeutic uses
Grant 8,178,528 - Hipskind , et al. May 15, 2
2012-05-15
Glucagon receptor antagonists, preparation and therapeutic uses
Grant 8,076,374 - Chappell , et al. December 13, 2
2011-12-13
Tetrasubstituted Pyridazine Hedgehog Pathway Antagonists
App 20110263602 - Bastian; Jolie Anne ;   et al.
2011-10-27
Thiazole pyrazolopyrimidines CRF1 receptor antagonists
Grant 8,030,304 - Chen , et al. October 4, 2
2011-10-04
Histamine H3 receptor agents, preparation and therapeutic uses
Grant 8,008,296 - Beavers , et al. August 30, 2
2011-08-30
Histamine H3 receptor agents, preparation and therapeutic uses
Grant 8,008,301 - Beavers , et al. August 30, 2
2011-08-30
Disubstituted Phthalazine Hedgehog Pathway Antagonists
App 20110190304 - Bastian; Jolie Anne ;   et al.
2011-08-04
Tetrasubstituted Pyridazines Hedgehog Pathway Antagonists
App 20110178093 - Bastian; Jolie Anne ;   et al.
2011-07-21
Disubstituted phthalazine hedgehog pathway antagonists
Grant 7,981,892 - Hipskind , et al. July 19, 2
2011-07-19
Pyrrolidine derivatives as histamine H3 receptor antagonists
Grant 7,951,826 - Beavers , et al. May 31, 2
2011-05-31
Histamine H3 receptor antagonists, preparation and therapeutic uses
Grant 7,902,191 - Beavers , et al. March 8, 2
2011-03-08
Disubstituted Phthalazine Hedgehog Pathway Antagonists
App 20110046143 - Hipskind; Philip Arthur ;   et al.
2011-02-24
Disubstituted Phthalazine Hedgehog Pathway Antagonists
App 20100324048 - Hipskind; Philip Arthur ;   et al.
2010-12-23
Substituted thiophene carboxylic amide glucagon receptor antagonists, preparation and therapeutic uses
Grant 7,807,702 - Chappell , et al. October 5, 2
2010-10-05
Thiazole pyrazolopyrimidines CRF1 receptor antagonists
App 20100222339 - Chen; Zhaogen ;   et al.
2010-09-02
Histamine H3 Receptor Agents, Preparation And Therapeutic Uses
App 20100160406 - Hipskind; Philip Arthur ;   et al.
2010-06-24
Histamine H3 Receptor Agents, Preparation And Therapeutic Uses
App 20100160319 - Beavers; Lisa Selsam ;   et al.
2010-06-24
Histamine H3 receptor agents, preparation and therapeutic uses
Grant 7,705,025 - Finley , et al. April 27, 2
2010-04-27
Histamine H3 Receptor Agents, Preparation And Therapeutic Uses
App 20100048580 - Beavers; Lisa Selsam ;   et al.
2010-02-25
Histamine H3 Receptor Agents, Preparation and Therapeutic Uses
App 20100029608 - FINLEY; Don Richard ;   et al.
2010-02-04
Thiophene Pyrazolopyrimidine Compounds
App 20100022560 - Chen; Zhaogen ;   et al.
2010-01-28
Imidazopyridazine compounds
Grant 7,612,067 - Barbosa , et al. November 3, 2
2009-11-03
Imidazopyridazine compounds
Grant 7,557,103 - Collins , et al. July 7, 2
2009-07-07
Glucagon Receptor Antagonists, Preparation And Therapeutic Uses
App 20090156655 - Conner; Scott Eugene ;   et al.
2009-06-18
Histamine H3 Receptor Agents, Preparation And Therapeutic Uses
App 20090048225 - Finley; Don Richard ;   et al.
2009-02-19
Glucagon Receptor Antagonists, Preparation and Therapeutic Uses
App 20080319074 - Chappell; Mark Donald ;   et al.
2008-12-25
Glucagon Receptor Antagonists, Preparation and Therapeutic Uses
App 20080300289 - Chappell; Mark Donald ;   et al.
2008-12-04
Pyrrolidine Derivatives as Histamine H3 Receptor Antagonists
App 20080207732 - Beavers; Lisa Selsam ;   et al.
2008-08-28
Imidazopyridazine Compounds
App 20080153828 - Collins; Elizabeth Aaron ;   et al.
2008-06-26
Imidazopyridazine Compounds
App 20080113978 - Barbosa; Heather Janelle ;   et al.
2008-05-15
Non-imidazole aryl alkylamines compounds as histamine H3 receptor antagonists, preparation and therapeutic uses
Grant 7,314,937 - Beavers , et al. January 1, 2
2008-01-01
Histamine H3 Receptor Agents, Preparation And Therapeutic Uses
App 20070208024 - Beavers; Lisa Selsam ;   et al.
2007-09-06
Thiophene-and thiazolesulfonamides as antineoplastic agents
Grant 7,250,430 - Grossman , et al. July 31, 2
2007-07-31
Histamine h3 receptor antagonists, preparation and therapeutic uses
App 20070155754 - Beavers; Lisa Selsam ;   et al.
2007-07-05
Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
Grant 7,229,987 - Ammenn , et al. June 12, 2
2007-06-12
Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents
Grant 7,183,320 - Shih , et al. February 27, 2
2007-02-27
Thiophene-and thiazolesulfonamides as antineoplastic agents
App 20060223871 - Grossman; Cora Sue ;   et al.
2006-10-05
Thiophene-amd thiazolesulfonamides as antineoplastic agents
Grant 7,084,170 - Grossman , et al. August 1, 2
2006-08-01
Histamine h3 receptor antagonists, preparation and therapeutic uses
App 20060167046 - Beavers; Lisa Selsam ;   et al.
2006-07-27
Tachykinin receptor antagonists
App 20060160794 - Amegadzie; Albert Kudzovi ;   et al.
2006-07-20
Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
App 20050272718 - Ammenn, Jochen ;   et al.
2005-12-08
Thiophene-amd thiazolesulfonamides as antineoplastic agents
App 20040198784 - Grossman, Cora Sue ;   et al.
2004-10-07
Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
App 20040110748 - Beavers, Lisa Selsam ;   et al.
2004-06-10
Benzimidzolyl neuropeptide Y receptor antagonists
App 20020007071 - Britton, Thomas Charles ;   et al.
2002-01-17
Benzimidzolyl neuropeptide Y receptor antagonists
Grant 6,255,494 - Britton , et al. July 3, 2
2001-07-03
2-acylaminopropanamides as growth hormone secretagogues
Grant 5,773,441 - Hipskind , et al. June 30, 1
1998-06-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed